We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ARTL market cap is 4.72M. The company's latest EPS is USD -3.1618 and P/E is -0.47.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -2.39M | -3.48M | -2.29M | -1.78M | -2.61M |
Net Income | -2.33M | -3.34M | -2.17M | -1.6M | -2.45M |
Year End 31 December 2022 | 2019 | 2020 | 2021 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -3.21M | -4.69M | -7.44M | -4.04M | -10.29M |
Net Income | -2.17M | -4.66M | -7.44M | -4.04M | -10.08M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 22.42M | 20.42M | 18.48M | 16.88M | 15.5M |
Total Liabilities | 512k | 1.02M | 840k | 609k | 921k |
Total Equity | 21.9M | 19.4M | 17.64M | 16.27M | 14.58M |
Year End 31 December 2022 | 2019 | 2020 | 2021 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 6.48M | 4.38M | 12.64M | 28.25M | 20.42M |
Total Liabilities | 1.02M | 502k | 593k | 1.08M | 1.02M |
Total Equity | 5.46M | 3.88M | 12.04M | 27.17M | 19.4M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -5.72M | -8.01M | -2.19M | -3.81M | -5.61M |
Investing | 1.16M | 2.96M | 2.2M | 2.6M | 766k |
Financing | -134k | N/A | N/A | N/A | 535k |
Year End 31 December 2022 | 2019 | 2020 | 2021 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -2.79M | -4.35M | -6.14M | -2.67M | -8.01M |
Investing | -1.5M | N/A | -3.44M | -10.03M | 2.96M |
Financing | 8.38M | 1.98M | 14.11M | 18.26M | N/A |
Market Cap | 4.72M |
Price to Earnings Ratio | -0.47 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0.69 |
Price to Book Ratio | 0.24 |
Dividend Yield | - |
Shares Outstanding | 3.19M |
Average Volume (1 week) | 14.48k |
Average Volume (1 Month) | 17.48k |
52 Week Change | -29.86% |
52 Week High | 2.98 |
52 Week Low | 1.15 |
Spread (Intraday) | 0.12 (7.84%) |
Company Name | Artelo Biosciences Inc |
Address |
564 wedge lane fernley, nevada 89408 |
Website | https://www.artelobio.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions